Paglalarawan

Genital herpes is a common sexually transmitted infection caused by the herpes simplex virus (HSV). It causes herpetic sores, which are painful blisters (fluid-filled bumps) that can break open and ooze fluid. Two types of the herpes simplex virus (HSV) cause genital herpes: HSV-1 and HSV-2. The World Health Organization stated that in 2016, about 3.7 billion people under age 50 years had contracted HSV-1. In the same year, around 491 million people ages 15 sa 49 years had an HSV-2 infection. A study by StrategyHelix indicates that the global genital herpes treatment market is expected to increase by US$ 580.4 milyon mula sa 2022 sa 2028, garnering a CAGR of 4.1% sa panahon ng pagtataya.

Ang ulat ay nagbibigay ng napapanahong data ng laki ng merkado para sa panahon 2018-2021 at forecast na 2028 covering key market aspects like sales value for genital herpes treatment. The global genital herpes treatment market is segmented on the basis of product, virus type, route of administration, channel ng pamamahagi, at rehiyon. Batay sa produkto, the global genital herpes treatment market is categorized into acyclovir, famciclovir, valacyclovir, iba pa ang iba. Globally, the acyclovir segment made up the largest share of the genital herpes treatment market. On the basis of virus type, the global genital herpes treatment market has been segmented into HSV-1, HSV-2. By route of administration, the global genital herpes treatment market has been segmented into injection, oral, topical. Ayon sa pananaliksik, the oral segment had the largest share in the global genital herpes treatment market. Batay sa channel ng pamamahagi, the global genital herpes treatment market is categorized into hospitals, online pharmacies, mga parmasya & drug stores. Sa mga tuntunin ng heograpiya, the global genital herpes treatment market has been segmented into North America, Asya Pasipiko, Europa, Pahinga ng Mundo (ROW).

The global genital herpes treatment market is highly competitive. The competitive landscape of the industry has also been examined along with the profiles of the key players Abbott Laboratories, Avet Pharmaceuticals Inc., Bausch Health Companies Inc., Cipla Limited, Eli Lilly and Company, Glenmark Pharmaceuticals Limited, GSK plc, Novartis AG, Pfizer Inc., Teva Pharmaceutical Industries Ltd., Viatris Inc.

Ang ulat ay isang napakahalagang mapagkukunan para sa mga kumpanya at organisasyon na aktibo sa industriyang ito. It provides a cohesive picture of the genital herpes treatment market to help drive informed decision making for industry executives, mga gumagawa ng patakaran, akademiko, at mga analyst.

Saklaw ng Ulat

Produkto: acyclovir, famciclovir, valacyclovir, iba pa ang iba
Virus type: HSV-1, HSV-2
Route of administration: injection, oral, topical
Pamamahagi ng channel: mga ospital, online pharmacies, mga parmasya & drug stores
Rehiyon: Hilagang Amerika, Asya Pasipiko, Europa, Pahinga ng Mundo (ROW)
Taon na itinuturing: Ang ulat na ito ay sumasaklaw sa panahon 2018 sa 2028

Mga Pangunahing Benepisyo para sa mga Stakeholder

– Get a comprehensive picture of the global genital herpes treatment market
– Pinpoint ang mga sektor ng paglago at mga trend para sa pamumuhunan

Talaan ng mga Nilalaman

Bahagi 1. Panimula
– Saklaw ng pag aaral
– Panahon ng pag aaral
– Saklaw ng heograpiya
– Paraan ng pananaliksik
Bahagi 2. Genital herpes treatment market overview
Bahagi 3. Pagkasira ng merkado sa pamamagitan ng produkto
– Acyclovir
– Famciclovir
– Valacyclovir
– Ang iba naman
Bahagi 4. Market breakdown by virus type
– HSV-1
– HSV-2
Bahagi 5. Market breakdown by route of administration
– Injection
– Oral
– Topical
Bahagi 6. Market breakdown by distribution channel
– Hospitals
– Online pharmacies
– Mga parmasya & drug stores
Bahagi 7. Market breakdown by region
– Hilagang Amerika
– Asya Pasipiko
– Europa
– Pahinga ng Mundo (ROW)
Bahagi 8. Mga pangunahing kumpanya
– Abbott Laboratories
– Avet Pharmaceuticals Inc.
– Bausch Health Companies Inc.
– Cipla Limited
– Eli Lilly and Company
– Glenmark Pharmaceuticals Limited
– GSK plc
– Novartis AG
– Pfizer Inc.
– Teva Pharmaceutical Industries Ltd.
– Viatris Inc.
Tungkol sa StrategyHelix
Pagtanggi